TP53 and breast cancer: Another study demonstrated that SIRT1 expression is inhibited by miR-211-5p by targeting SIRT1 via its 3′-UTR, and miR-211-5p expression culminated in decreased acetylation of p53, which was associated with reduced cell viability and apoptosis induction in breast cancer cells [206].